Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 140, Issue 2, Pages 123-132Publisher
WILEY
DOI: 10.1111/j.1365-2141.2007.06909.x
Keywords
myelodysplasia; acute myeloid leukaemia; familial; RUNX1; CEBPA
Categories
Ask authors/readers for more resources
Familial occurrence of myelodysplasia (MDS) and/or acute myeloid leukaemia (AML) is rare but can provide a useful resource for the investigation of predisposing mutations in these myeloid malignancies. To date, examination of families with MDS/AML has lead to the detection of two culprit genes, RUNX1 and CEBPA. Germline mutations in RUNX1 result in familial platelet disorder with propensity to myeloid malignancy and inherited mutations of CEBPA predispose to AML. Unfortunately, the genetic cause remains obscure in most other reported pedigrees. Further insight into the molecular mechanisms of familial MDS/AML will require awareness by clinicians of new patients with relevant family histories.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available